홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
  1. 홈
  2. /화합물

갈라민 트리에티오다이드

Gallamine Triethiodide

HCID 6172
노트반응
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
65-29-2
표준 SMILES
CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]
InChIKey
REEUVFCVXKWOFE-UHFFFAOYSA-K
분자식
C30H60I3N3O3
평균 분자량
891.5 g/mol
단동위원소 질량
891.1769

개요

A synthetic nondepolarizing blocking drug. The actions of gallamine triethiodide are similar to those of tubocurarine, but this agent blocks the cardiac vagus and may cause sinus tachycardia and, occasionally, hypertension and increased cardiac output. It should be used cautiously in patients at risk from increased heart rate but may be preferred for patients with bradycardia. (From AMA Drug Evaluations Annual, 1992, p198)

이름 및 식별자

우선 이름
Gallamine Triethiodide
IUPAC
2-[2,3-bis[2-(triethylazaniumyl)ethoxy]phenoxy]ethyl-triethylazanium triiodide
현지명
갈라민 트리에티오다이드
영어명
Gallamine triethiodide
분자식
C30H60I3N3O3
분자량
891.53

이름 및 동의어

GALLAMINE TRIETHIODIDE65-29-2FlaxedilBenzcurine iodideRemyolanSyncurarineRelaxanSincurarineRetensinTricuranGallaminii iodidumGallamine-3ETI
이름 더 보기
갈라민트리에티오다이드갈라민트라이에티오다이드갈라민 트라이에티오다이드gallaminef2559rp3697gallaminflacedil
Gallamine triiodoethylateFourneau 2559Gallamine iodideGallamina triodoetilatoGallamini triethiodidumTriethiodure de gallamineGallamin triethiodideGallamone triethiodide

데이터베이스 식별자

CAS
65-29-2
PubChem CID
6172
DTXSID
DTXSID5023089
ChEMBL
CHEMBL1200993
UNII
Q3254X40X2
EC Number
200-605-1

물성

구조 계산 물성

극성 표면적
27.7 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
6
회전 가능 결합 수
21
무거운 원자 수
39
형식 전하
0
복잡도
489

실험 및 물리화학적 성질

OdorODORLESS
Color/Form · 2건

WHITE AMORPHOUS POWDER

White crystals from acetone/water

Solubility · 3건

Soluble

Freely sol in water, alcohol, dil acetone; sparingly sol in anhyd acetone, ether, benzene, chloroform

Very soluble in water and ethanol; slightly soluble in ethyl ether and acetone.

Human Drugs · 2건

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

DecompositionWhen heated to decomposition it emits very toxic fumes of ammonia, nitroxides, and iodine.
Melting Point · 2건

152-153

147.5 °C

Other Experimental PropertiesHYGROSCOPIC

물리화학적 성질

녹는점
235 °C · 235 °C (dec.) (lit.)
밀도
1.4288 · 1.4288 (estimate)
저장 조건
2 · 2-8°C
용해도
2 O: · H2O: 100 mg/mL
물리적 상태
가루
색상
2 CO · Me2CO 수용액에서 결정화
수용성
2 O: · H2O: 100mg/mLethanol: soluble
Merck
13 · 13,4364
InChIKey
REEUVFCVXKWOFE-UHFFFAOYSA-K
SMILES
C1(OCC[N+](CC)(CC)CC)=C(C=CC=C1OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-]

화학적 성질

White Solid

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory InformationEthanaminium, 2,2',2''-[1,2,3-benzenetriyltris(oxy)]tris[N,N,N-triethyl-, triiodide: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - Ethanaminium, 2,2',2''-[1,2,3-benzenetriyltris(oxy)]tris[N,N,N-triethyl-, triiodide: Human health tier I assessment
FDA Requirements · 1건

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Hazard Classes and CategoriesAcute Tox. 4 (100%)

안전 및 보호

Disposal Methods · 1건

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

독성 정보

Interactions · 5건

IN ANESTHETIZED PT, IV ADMIN OF DIAZEPAM MAY INCR INTENSITY & PROLONG DURATION OF NEUROMUSCULAR BLOCKADE PRODUCED BY GALLAMINE TRIETHIODIDE. CLINICAL REPORTS...ARE CONFLICTING.../&/ THERE ARE INSUFFICIENT DATA TO EXPLAIN POSSIBLE MECHANISM FOR GALLAMINE TRIETHIODIDE-DIAZEPAM INTERACTION.

NEUROMUSCULAR BLOCKADE PRODUCED BY TUBOCURARINE WAS PROLONGED IN TWO THYROTOXIC PT RECEIVING HIGH DOSES (120 MG/DAY FOR 14 DAYS) OF PROPRANOLOL. ... ALTHOUGH THERE IS NO DOCUMENTATION, THE NONDEPOLARIZING MUSCLE RELAXANT GALLAMINE TRIETHIODIDE...ALSO SHOULD INTERACT WITH PROPRANOLOL.

NEOMYCIN &...RELATED ANTIBIOTICS PRODUCE NEUROMUSCULAR TRANSMISSION FAILURE WHICH MAY CAUSE PROLONGED RESP DEPRESSION OR APNEA IN SURGICAL PT TREATED CONCURRENTLY WITH TUBOCURARINE &...NEUROMUSCULAR DEPRESSANTS. ...ADDITIVE NEUROMUSCULAR DEPRESSION.../REPORTED TO OCCUR WITH GALLAMINE TRIETHIODIDE/.

QUINIDINE, ADMIN PARENTERALLY SHORTLY AFTER OR SIMULTANEOUSLY WITH TUBOCURARINE, MAY ENHANCE OR CAUSE RECURRENT NEUROMUSCULAR EFFECTS OF TUBOCURARINE, RESULTING IN PROLONGATION OR INTENSIFICATION OF RESP DEPRESSION & APNEA. ... GALLAMINE TRIETHIODIDE...HAS BEEN SHOWN TO INTERACT WITH QUINIDINE IN ANIMALS.

For more Interactions (Complete) data for GALLAMINE TRIETHIODIDE (25 total), please visit the HSDB record page.

Human Toxicity Excerpts · 3건

POISONING ... IS ALMOST ALWAYS RESULT OF CLINICAL OVERDOSAGE ... DIRECTLY RELATED FACTORS MAY ... INCL ALTERATIONS IN BODY TEMP ... ELECTROLYTE IMBALANCE, PARTICULARLY OF POTASSIUM ... /NEUROMUSCULAR BLOCKING AGENTS/

THREE CASES OF SEVERE ANAPHYLAXIS TO GALLAMINE TRIETHIODIDE ARE DESCRIBED. ALL REPORTED CASES HAVE OCCURRED IN WOMEN, & ALL CONFIRMED CASES IN AUSTRALASIA. THERE IS EVIDENCE THAT WOMEN MAY BE EXPOSED TO SOME SUBSTANCE WHICH LEAVES THEM SENSITIVE TO GALLAMINE TRIETHIODIDE.

Accidental subarachnoid injection of gallamine in an adult is followed by muscle spasms of the lower limbs and anxiety; by 3 hr the arterial pressure and pulse rate increases followed by hyperthermia, profuse sweating, intense hyperesthesia, loss of consciousness, and pinpoint pupils. Within 24 hr the muscle spasms lessen.

Drug Induced Liver Injury · 5건

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

gallamine triethiodide

DILI Negative

Intravenous

DOI:10.1016/j.drudis.2019.09.022

Non-Human Toxicity Excerpts · 5건

LD50 VALUES OF GALLAMINE TRIETHIODIDE AFTER IV, IP, & SC INJECTIONS WERE 3.0-3.3, 15.3-15.8, & 16.4-17.1 MG/KG IN MICE. VALUES AFTER ORAL ADMIN WERE GREATER THAN 1000 MG/KG. RESP DISORDER WAS MAJOR CAUSE OF DEATH.

LD50 VALUES OF GALLAMINE TRIETHIODIDE AFTER IV, IP, & SC INJECTIONS WERE 5.1-5.4, 23.2-26.7 & 28.5-34.3 MG/KG IN RATS. VALUES AFTER ORAL ADMIN WERE GREATER THAN 1000 MG/KG. IV LD50 IN RABBITS WAS 0.46 MG/KG. RESP DISORDER WAS MAJOR CAUSE OF DEATH IN THESE ANIMALS.

COMPARED TO CONTROL ANIMALS, ONSET OF ACTION OF GALLAMINE TRIETHIODIDE WAS SIGNIFICANTLY DELAYED IN HEMORRHAGIC (HYPOTENSIVE) DOGS. RECOVERY FROM GALLAMINE TRIETHIODIDE INDUCED PARALYSIS OCCURRED IN CONTROL DOGS, BUT NO SIGNS OF RECOVERY IN HEMORRHAGIC ANIMALS.

BLOOD & TISSUE SAMPLES WERE TAKEN FROM MALE RATS PREVIOUSLY TREATED IV WITH NEUROMUSCULAR BLOCKING AGENTS. GALLAMINE TRIETHIODIDE (40 MG/KG) WAS MODERATE HISTAMINE LIBERATOR. PANCURONIUM BROMIDE (2 MG/KG) RELEASED NO HISTAMINE. SOURCES OF INCR BLOOD HISTAMINE CONCN ARE TONGUE & SKIN WITH HIGH HISTAMINE CONTENT. NO RELEASE OF HISTAMINE FROM LUNG WAS OBSERVED.

For more Non-Human Toxicity Excerpts (Complete) data for GALLAMINE TRIETHIODIDE (7 total), please visit the HSDB record page.

Non-Human Toxicity Values · 5건

LD50 Rat ip 23,200 ug/kg

LD50 Rat sc 28,500 ug/kg

LD50 Rat iv 5100 ug/kg

LD50 Rat intraduodenal 380 mg/kg

For more Non-Human Toxicity Values (Complete) data for GALLAMINE TRIETHIODIDE (13 total), please visit the HSDB record page.

규제 정보

FDA Requirements · 1건

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

안전 데이터

wgk
3
rtecs
BS1100000
독성
LD50 oral in rabbit: 100mg/kg
HS 번호
29239000
risk_code
22-36/37/38
hazard_code
Xn
safety_code
26-36-45
Hazard Classifications
Acute Tox. 4 Oral
스토리지 클래스
11 - Combustible Solids
유해 물질 데이터
65-29-2(Hazardous Substances Data)

화학 및 산업

약리 정보

Pharmacodynamics · 1건

Gallamine Triethiodide is a nondepolarizing neuromuscular blocking drug (NDMRD) used as an adjunct to anesthesia to induce skeletal muscle relaxation. The actions of gallamine triethiodide are similar to those of tubocurarine, but this agent blocks the cardiac vagus and may cause sinus tachycardia and, occasionally, hypertension and increased cardiac output. Muscle groups differ in their sensitivity to these types of relaxants with ocular muscles (controlling eyelids) being most sensitive, followed by the muscles of the neck, jaw, limbs and then abdomen. The diaphragm is the least sensitive muscle to NDMRDs. Although the nondepolarizing neuromuscular blocking drugs do not have the same adverse effects as succinylcholine, their onset of action is slower. They also have a longer duration of action, making them more suitable for maintaining neuromuscular relaxation during major surgical procedures.

Mechanism of Action · 4건

It competes with acetylcholine (ACh) molecules and binds to muscarinic acetylcholine receptors on the post-synaptic membrane of the motor endplate. It acts by combining with the cholinergic receptor sites in muscle and competitively blocking the transmitter action of acetylcholine. It blocks the action of ACh and prevents activation of the muscle contraction process. It can also act on nicotinic presynaptic acetylcholine receptors which inhibits the release of ACh.

GALLAMINE TRIETHIODIDE...PRODUCES SKELETAL MUSCLE RELAXATION BY COMBINING WITH RECEPTOR SITE AT NEUROMUSCULAR JUNCTION & BLOCKING ACTION OF NEUROTRANSMITTER ACETYLCHOLINE.

IN RAT PHRENIC NERVE-DIAPHRAGM GALLAMINE HAD NO SIGNIFICANT EFFECTS ON ELECTROGENIC PROPERTIES OF EXCITABLE MEMBRANES OF MOTOR NERVE TERMINALS & MUSCLE FIBERS; IT DEPRESSED RESPONSE OF POSTSYNAPTIC RECEPTORS TO ACTION OF ACETYLCHOLINE.

AT NEUROMUSCULAR JUNCTIONS IN MICE AND FROGS, FOLLOWING STEP CHANGES OF MEMBRANE POTENTIAL FROM -70 TO -130 MV, GALLAMINE (5 UMOL) IN THE PRESENCE OF ACETYLCHOLINE (3 UMOL) CAUSED AN INITIAL RAPID DECR IN CURRENT FOLLOWED BY OPENING OF CHANNELS AT A SLOWER RATE THAN WITH ACETYLCHOLINE ALONE. WHEN THE INTERNAL POTENTIAL WAS REDUCED TO -70 MV, THERE WAS A RAPID INCR IN CURRENT AT FIRST, FOLLOWED BY THE USUAL DECR WHICH WAS AGAIN SLOWER THAN NORMAL. THUS, GALLAMINE MAY PRODUCE A POTENTIAL-DEPENDENT BLOCK OF OPEN ION CHANNELS.

Biological Half-Life135 minutes /From table/
Metabolism/Metabolites.../GALLAMINE/ IS UNMETABOLIZED. /GALLAMINE/
MeSH Pharmacological Classification · 2건

Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants.

Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses.

Absorption, Distribution and Excretion · 5건

STUDIES HAVE DEMONSTRATED THAT GALLAMINE IS EXCRETED IN DOG URINE AT RATE FASTER THAN OTHER MUSCLE RELAXANTS. .../IT/ DID NOT CROSS BLOOD-CEREBROSPINAL FLUID BARRIER. OTHER STUDIES...HAVE DETECTED GALLAMINE IN CEREBROSPINAL FLUID IN CONCN APPROACHING THOSE IN PLASMA DURING 1ST HR AFTER IV INJECTION. /GALLAMINE/

GALLAMINE IS ELIMINATED MAINLY BY RENAL EXCRETION...

... GALLAMINE CROSSES PLACENTAL BARRIER ...

TRACE AMT OF GALLAMINE APPEARS IN FETUS 3 MIN AFTER ADMIN. /GALLAMINE, FROM TABLE/

For more Absorption, Distribution and Excretion (Complete) data for GALLAMINE TRIETHIODIDE (6 total), please visit the HSDB record page.

용도 및 제조

UsesMEDICATION
Methods of Manufacturing · 2건

PYROGALLOL IS CONDENSED WITH 2-CHLOROTRIETHYLAMINE & RESULTING TRIAMINE [2,2''',2''''''-(V-PHENENYLTRIOXY)TRIS(TRIETHYLAMINE)] IS QUATERNIZED WITH ETHYL IODIDE IN BOILING ACETONE. CRUDE PRODUCT WHICH PPT IS PURIFIED BY REPEATED CRYSTALLIZATION FROM HOT ETHANOL.

Prepared by reaction of pyrogallol with diethylaminoethyl chloride and subsequent alkylation with ethyl iodide.

Formulations/PreparationsGALLAMINE TRIETHIODIDE, USP (FLAXEDIL), IS AVAIL AS STERILE SOLN CONTAINING 20 OR 100 MG/ML.
General Manufacturing InformationPharmaceutical incompatibilities: meperidine hydrochloride (solutions must not be mixed /with gallamine triethiodide/).
응용 분야 · 2건

용도Gallamine Triethiodide is used as a neuromuscular blocking agent, paralyzing locally during anesthetization.

일반 설명Gallamine triethiodide,[v-phenenyl-tris(oxyethylene)]tris[triethylammonium] triiodide(Flaxedil), is a skeletal muscle relaxant that works byblocking neuromuscular transmission in a manner similar tothat of d-tubocurarine (i.e., a nondepolarizing blockingagent). It does have some differences, however. It has astrong vagolytic effect and a persistent decrease in neuromuscularfunction after successive doses that cannot be overcome by cholinesterase inhibitors. Gallamine triethiodidealso has muscarinic antagonistic properties and bindswith greater affinity to the M2 receptors than to the M1 receptor.This latter characteristic may cause its strongvagolytic action.

상·하류 제품 정보

상류 원료

피로갈롤요오드화에틸나트륨아미드2,2',2"-[벤젠-1,2,3-트리일트리(옥시)]트리스[N,N-디에틸에틸아민]

공급사94 곳

国药集团化学试剂有限公司86-21-63210123 · [email protected]
北京华美互利生物化工010-56205725 · [email protected]
阿诺西(上海)生物技术有限公司400-1107768 15058188853 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
湖南韵邦生物科技股份有限公司0731-88532326 13319508186 · [email protected]
Hebei Chuanghai Biotechnology Co., Ltd+86-17732866630 · [email protected]
上海康朗生物科技有限公司021-61998208 18217752821 · [email protected]
成都超九八生物科技有限公司13348960310 13348960310 · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
上海如吉生物科技发展有限公司+86-21-65211385-8001 36031160 · [email protected]
Dayang Chem (Hangzhou) Co.,Ltd.+86-0571-88938639 17705817739 · [email protected]
Hebei Yanxi Chemical Co., Ltd.+86-17531190177 · [email protected]
浙江珲达生物科技有限公司0571-89903022 18679456698 · [email protected]
上海弘顺生物科技有限公司15901914505 · [email protected]
上海颖心实验室设备有限公司021-59178156 17002132182 · [email protected]
广东元丰化学试剂有限公司0751-2829979 13318593351 · [email protected]
广东云星生物技术有限公司0751-18902340975/189023400307 18902340307 · [email protected]
MedBio脉铂医药021-69568360 18916172912 · [email protected]
怀化市冰峰化工有限公司0745-2866851 17711757908 · [email protected]
Nanjing Duly Biotech Co.,Ltd+86-18013301590 · [email protected]
医恩医疗系统研发(上海)有限公司021-58958002 18930822973 · [email protected]
广东谦进化学试剂有限公司0751-2818792 13435114148 · [email protected]
BOC Sciences1-631-485-4226; 16314854226 · [email protected]
湖北扬信医药科技有限公司0714-3999001 19171453112 · [email protected]
ChemeGen 中国18818260767 · [email protected]
四川库利南科技有限公司400-1166-196 18981987031 · [email protected]
斯百全化学(上海)有限公司021-021-021-67601398-809-809-809 15221380277 · [email protected]
上海思域化工科技有限公司86-21-34053660 · [email protected]
AdooQ BioScience, LLC+1 (866) 930-6790 · [email protected]
江苏艾康生物医药研发有限公司025-66113011 13913916777 · [email protected]
TOKYO CHEMICAL INDUSTRY CO., LTD.03-36680489 · [email protected]
TCI Europe320-37350700 · [email protected]
南京杜莱生物技术有限公司025-84699383-8003;025-846993838003-8003 18013301590 · [email protected]
南京世洲生物科技有限公司13675144456 · [email protected]
上海将来实业股份有限公司400-0066400 13621662912 · [email protected]
上海毕得医药科技股份有限公司400-164-7117 18317119277 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
陕西缔都医药化工有限公司+86-29-87569262 +86-15003564040 · [email protected]
南京百鑫德诺生物科技有限公司025-58849295 · [email protected]
Chongqing jooe co., ltd+86-15223382610 · [email protected]
凯试(上海)科技有限公司021-50135380 · [email protected]
上海谱科生物技术有限公司021-64705760 18027310741 · [email protected]
Sigma-Aldrich西格玛奥德里奇(上海)贸易有限公司021-61415566 800-8193336 · [email protected]
TargetMol中国(陶术生物)021-021-33632979 15002134094 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
北京诺其雅盛生物科技有限公司4000-819-385 010-62329685 13718666987
上海谱振生物科技有限公司4001650900 13817534909 · [email protected]
广东翁江化学试剂有限公司0751-2815987 13927875076 · [email protected]
HANGZHOU LEAP CHEM CO., LTD.+86-571-87711850 +86-15355479329 · [email protected]
艾吉析科技(上海)有限公司17717235263 17717235263 · [email protected]

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트